Nitric Oxide Synthase Inhibition Protects Against Rotenone-Induced Neurodegeneration in vivo

: Neuropathologic and motor features of Parkinson’s disease can be induced in rodents by the pesticide rotenone. In this study, we aimed to determine whether nitric oxide synthase inhibition by N G -nitro-L-arginine methyl ester (L-NAME) could prevent neurodegeneration and biochemical changes induced by rotenone in rat brain. For this purpose, rats received subcutaneous injections of rotenone (1.5 mg/kg) every other day for two consecutive weeks and were treated at the same time with L-NAME at doses of 10 or 20 mg/kg, intraperitoneally. Oxidative stress indictors, malondialdehyde, reduced glutathione, and nitric oxide as well as paraoxonase-1 (PON-1) activity in brain, and the concentration of the antiapoptotic protein B cell/lymphoma-2 (Bcl2) in striatum were determined. Motor strength and coordination was assessed using wire hanging and stair tests. Neuronal degeneration was evaluated using hematoxylin & eosin-stained brain sections. Results: L-NAME reduced, in a dose-dependent manner the increase in lipid peroxidation (malondialdehyde) and nitric oxide and restored reduced glutathione levels in brain of rotenone-treated rats. Additionally, L-NAME prevented the inhibition of paraoxonase-1 activity and the decrease in Bcl2 concentration induced by the pesticide. It also prevented motor impairments in a dose-dependent manner. Furthermore, L-NAME treatment ameliorated the neurodegenerative effects of rotenone, as shown by the decrease in degenerated neurons in striatum and cerebral cortex. The results of the present study suggest that rotenone mediates its neurotoxic effects, at least in part by nitric oxide-dependent mechanisms.

[1]  M. Afify,et al.  Modafinil Alleviates Rotenone-Induced Neurochemical changes and Striatal Neurodegeneration via Inhibiting Oxidative Stress and Neuroinflammation , 2020, Egyptian Journal of Chemistry.

[2]  J. Jankovic,et al.  Parkinson’s disease: etiopathogenesis and treatment , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  E. Youness,et al.  Neuroprotective Effects of the Glutathione Precursor N-Acetylcysteine against Rotenone-Induced Neurodegeneration , 2019, Reactive Oxygen Species.

[4]  F. N. Emamzadeh,et al.  Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors , 2018, Front. Neurosci..

[5]  A. Abramov,et al.  Role of mitochondrial ROS in the brain: from physiology to neurodegeneration , 2018, FEBS letters.

[6]  E. Youness,et al.  Neuroprotection by misoprostol against rotenone-induced neurotoxicity in rat brain , 2018 .

[7]  E. Youness,et al.  The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats , 2015, Comparative Clinical Pathology.

[8]  J. Duarte,et al.  Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach. , 2014, Toxicology letters.

[9]  J. Hussein,et al.  Nigrostriatal damage after systemic rotenone and/or lipopolysaccharide and the effect of cannabis , 2014, Comparative Clinical Pathology.

[10]  Peter E. Czabotar,et al.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.

[11]  J. Sinsheimer,et al.  Household organophosphorus pesticide use and Parkinson's disease. , 2013, International journal of epidemiology.

[12]  J. Sinsheimer,et al.  Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure. , 2013, Environment international.

[13]  M. Varghese,et al.  Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats , 2013, Neurochemistry International.

[14]  S. Koifman,et al.  Pesticide exposure and Parkinson's disease: epidemiological evidence of association. , 2012, Neurotoxicology.

[15]  Chi Li,et al.  The Bcl-2 proteins Noxa and Bcl-xL co-ordinately regulate oxidative stress-induced apoptosis. , 2012, The Biochemical journal.

[16]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[17]  J. Blesa,et al.  Classic and New Animal Models of Parkinson's Disease , 2012, Journal of biomedicine & biotechnology.

[18]  T. Ng,et al.  Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism , 2012, Chinese Medicine.

[19]  H. Adami,et al.  Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.

[20]  Tatiana Foroud,et al.  Genetics of Parkinson disease , 2004, Genetics in Medicine.

[21]  Guy C. Brown,et al.  Nitric oxide and neuronal death. , 2010, Nitric oxide : biology and chemistry.

[22]  D. Green,et al.  The BCL-2 family reunion. , 2010, Molecular cell.

[23]  H. Park,et al.  Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. , 2009, Toxicology.

[24]  Victor Tapias,et al.  A highly reproducible rotenone model of Parkinson's disease , 2009, Neurobiology of Disease.

[25]  Nguyen Dang Hung,et al.  Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1). , 2009, Biochimica et biophysica acta.

[26]  M. Watabe,et al.  Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells , 2008, Molecular Pharmacology.

[27]  J. Andersen,et al.  Oxidative and nitrative protein modifications in Parkinson's disease. , 2008, Free radical biology & medicine.

[28]  Eden R Martin,et al.  Pesticide exposure and risk of Parkinson's disease: A family-based case-control study , 2008, BMC neurology.

[29]  S. Moncada,et al.  Nitric oxide, cell bioenergetics and neurodegeneration , 2006, Journal of neurochemistry.

[30]  A. Vinogradov,et al.  Generation of superoxide by the mitochondrial Complex I. , 2006, Biochimica et biophysica acta.

[31]  V. Nair,et al.  The thiobarbituric acid test for lipid peroxidation: Structure of the adduct with malondialdehyde , 1984, Lipids.

[32]  D. Sok,et al.  Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids Published, JLR Papers in Press, September 16, 2004. DOI 10.1194/jlr.M400144-JLR200 , 2004, Journal of Lipid Research.

[33]  Werner J. Schmidt,et al.  Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain , 2004, Experimental Neurology.

[34]  T. Araki,et al.  Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study , 2004, European Neuropsychopharmacology.

[35]  B. La Du,et al.  Pharmacogenetics of paraoxonases: a brief review , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[36]  Todd B. Sherer,et al.  Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.

[37]  Joseph Jankovic,et al.  Role of nitric oxide in rotenone‐induced nigro‐striatal injury , 2003, Journal of neurochemistry.

[38]  P. Boon,et al.  The pathophysiology of motor symptoms in Parkinson's disease. , 2003, Acta neurologica Belgica.

[39]  J. Paul Robinson,et al.  Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production* , 2003, The Journal of Biological Chemistry.

[40]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[41]  P. Hien,et al.  ROTENONE - POTENTIAL AND PROSPECT FOR SUSTAINABLE AGRICULTURE , 2003 .

[42]  Y. Vodovotz,et al.  The Chemical Biology of Nitric Oxide , 2002 .

[43]  B. Trump,et al.  BCL-2 is involved in preventing oxidant-induced cell death and in decreasing oxygen radical production , 2001, Redox report : communications in free radical research.

[44]  M. Rigoulet,et al.  Mitochondrial ROS Metabolism: Modulation by Uncoupling Proteins , 2001, IUBMB life.

[45]  S. Dunnett,et al.  The staircase test of skilled reaching in mice , 2001, Brain Research Bulletin.

[46]  T. Dawson,et al.  The role of nitric oxide in Parkinson's disease. , 2001, Methods in molecular medicine.

[47]  N. Tatton Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease , 2000, Experimental Neurology.

[48]  Jacqueline N. Crawley,et al.  What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice , 2000 .

[49]  Ted M. Dawson,et al.  Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease , 1999, Nature Medicine.

[50]  C. Cotman,et al.  Bcl-2 Facilitates Recovery from DNA Damage after Oxidative Stress , 1999, Experimental Neurology.

[51]  S. Archer,et al.  Measurement of nitric oxide in biological models , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  A. Brock,et al.  A New Automated Method for Phenotyping Arylesterase (EC 3.1.1.2) Based Upon Inhibition of Enzymatic Hydrolysis of 4-Nitrophenyl Acetate by Phenyl Acetate , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[53]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.